SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 32 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $8,162,000 | +681.8% | 4,471,000 | +935.0% | 0.90% | +666.9% |
Q3 2014 | $1,044,000 | -83.4% | 432,000 | -86.5% | 0.12% | -84.1% |
Q2 2014 | $6,290,000 | -19.1% | 3,200,000 | -30.5% | 0.74% | -12.2% |
Q1 2014 | $7,777,000 | -20.8% | 4,605,000 | -30.2% | 0.84% | -20.4% |
Q4 2013 | $9,814,000 | +21.6% | 6,595,000 | +0.6% | 1.06% | +12.2% |
Q3 2013 | $8,071,000 | +12.1% | 6,555,000 | +9.1% | 0.95% | +7.9% |
Q2 2013 | $7,197,000 | – | 6,010,000 | – | 0.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GRACE BROTHERS MANAGEMENT LLC | 2,800,000 | $5,117,000 | 4.90% |
SILVERBACK ASSET MANAGEMENT LLC | 18,209,000 | $33,322,000 | 4.30% |
RAVEN ROCK CAPITAL MANAGEMENT, LLC | 1,000,000 | $1,990,000 | 2.80% |
Verition Fund Management LLC | 5,504,000 | $10,062,000 | 2.26% |
CAMDEN ASSET MANAGEMENT L P /CA | 26,798,000 | $48,856,000 | 1.81% |
GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,600,000 | $15,679,000 | 1.60% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 3,000,000 | $5,490,000 | 1.46% |
BASSO CAPITAL MANAGEMENT, L.P. | 4,825,000 | $8,782,000 | 1.40% |
Wellesley Asset Management | 12,564 | $23,006,000 | 1.35% |
WOLVERINE ASSET MANAGEMENT LLC | 31,156,000 | $56,979,000 | 1.11% |